GYKI-52466: a potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy.
Nandhu
M S
MS
Paul
Jes
J
Mathew
Jobin
J
Peeyush Kumar
T
T
Paulose
C S
CS
D001569:Benzodiazepines / Q000008:administration & dosage*; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D008959:Models, Neurological; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors*
D018091:Receptors, AMPA; C061950:GYKI 52466; D001569:Benzodiazepines; D018698:Glutamic Acid